suggest that PS1 mutations may promote neuronal dysfunction and degeneration by altering cellular calcium homeostasis. On the other hand, it has been suggested that age-related damage to DNA in neurons may be an important early event in the pathogenesis of AD. We now report that PC12 cells and primary hippocampal neurons expressing mutant PS1 exhibit increased sensitivity to death induced by DNA damage. The hypersensitivity to DNA damage is correlated with increased intracellular Ca 2؉ levels, induction of p53, upregulation of the Ca 2؉ -dependent protease m-calpain, and mitochondrial membrane depolarization. Moreover, activation of caspase-12, an endoplasmic reticulum (ER)-associated caspase, is greatly increased in cells expressing mutant PS1. DNA damage-induced death of cells expressing mutant PS1 was attenuated by inhibitors of calpains I and II, by an intracellular Ca 2؉ chelator, by the protein synthesis inhibitor cycloheximide, and by a broad-spectrum caspase inhibitor, but not by an inhibitor of caspase-1. Agents that release Ca 2؉ from the ER increased the vulnerability of cells expressing mutant PS1 to DNA damage. By promoting ER-mediated apoptotic proteolytic cascades, PS1 mutations may sensitize neurons to DNA damage. © 2002 Elsevier Science (USA)
INTRODUCTION
Alzheimer's disease (AD) 1 is characterized by the death of neurons in brain regions that function in learning and memory processes. Analyses of postmortem brain tissue from AD patients, and of experimental cell culture and animal models of AD, suggest roles for oxidative stress and nuclear DNA damage in the neurodegenerative process (Robison & Bradley, 1984; Mullaart et al., 1990; Markesbery, 1997; Su et al., 1997; Adamec et al., 1999; Anderson et al., 2000; Kruman et al., 2000) . DNA damage can trigger apoptosis, a form of programmed cell death also implicated in the pathogenesis of AD and related disorders (for review see Mattson, 2000) . Playing a pivotal role in neuronal death triggered by DNA damage is the tumor suppressor protein p53 (Enokido et al., 1996; Cregan et al., 1999) , which acts by upregulating the expression of genes encoding pro-
